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Abstract
The inhibition of human motor endplate cholinesterase by anticholinesterase compounds was
studied using isolated muscle membrane preparation. Ambenonium was most potent, and edro-
phonium was least potent in inhibiting motor endplate cholinesterase. The slope of the regres-
sion line for inhibition of motor endplate cholinesterase was greatest for ambenonium, and small-
est for neostigmine and edrophonium. These compounds were less potent inhibitors of plasma
cholinesterase. Ambenonium was more specific, and other compounds were less specific in-
hibitors of motor endplate cholinesterase. In myasthenic patients, these compounds produced
adequate inhibition of motor endplate cholinesterase even in the presence of relatively mild plasma
cholinesterase inhibition.
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